3-Hour Virtual Seminar on FDA's Scrutiny of Social Media Promotion
View: 222
Website www.traininng.com/webinar/3-hour-virtual-seminar-on-fda's-scrutiny-of-social-media-promotion--200598 |
Edit Freely
Category Regulatory Directors, Marketing Directors, Quality Systems Auditors, Recall Managers
Deadline: March 11, 2019 | Date: March 12, 2019
Venue/Country: Online, U.S.A
Updated: 2019-01-31 18:18:58 (GMT+9)
Call For Papers - CFP
OverviewFDA steadily expands the scope and restrictions for promotion of products under its jurisdiction. Whatever and where ever to want to talk about your product, just assume your talking to FDA.Trolling for off-label information in social media, scrutiny of educational material under "safe harbor" and apparent conflicts of interest at a public event create a sink hole for firms even though it may seem innocent in your eyes.Facebook, Twitter or chat rooms can be rampant with off-label information. You even may be surprised about what people are saying about your product. Does FDA hold you accountable?Why should you AttendLimitations on commercial free speechAvenues of off-label informationWorking in a "safe harbor" for off-label information distributionSocial media and your regulatory responsibilitiesCorrecting off-label informationFactoring in cognitive psychologyAreas Covered in the SessionLearn to navigate through FDA requirementsUnderstand that your right to free speech is limitedHow to get around FDA prohibitionsWays to manage your presence in social mediaHow to identify an off-label problem and corrective actionUnder how FDA applies cognitive psychology principlesWho Will BenefitRegulatory DirectorsMarketing DirectorsQuality Systems AuditorsRecall ManagersIn-house Legal CounselCustomer Support StaffSales StaffSpeaker ProfileCasper (Cap) Uldriks through his firm "Encore Insight LLC," brings over 32 years of experience from the FDA. He specialized in the FDA's medical device program as a field investigator, served as a senior manager in the Office of Compliance and an Associate Center Director for the Center for Devices and Radiological Health. He developed enforcement actions and participated in the implementation of new statutory requirements. His comments are candid, straightforward and of practical value.
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.